These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
472 related items for PubMed ID: 23075721
1. Thiopurine methyltransferase gene polymorphisms and activity in Chinese patients with inflammatory bowel disease treated with azathioprine. Zhu Q, Cao Q. Chin Med J (Engl); 2012 Oct; 125(20):3665-70. PubMed ID: 23075721 [Abstract] [Full Text] [Related]
3. Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease? Fangbin Z, Xiang G, Minhu C, Liang D, Feng X, Min H, Pinjin H. Ther Drug Monit; 2012 Dec; 34(6):695-701. PubMed ID: 23149442 [Abstract] [Full Text] [Related]
13. The impact of thiopurine-S-methyltransferase genotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseases. Hlavaty T, Batovsky M, Balakova D, Pav I, Celec P, Gregus M, Zakuciova M, Hlista M, Horakova M, Desatova B, Koller T, Toth J, Kadasi L, Huorka M, Slovak IBD study group (SK IBD). Bratisl Lek Listy; 2013 Dec; 114(4):199-205. PubMed ID: 23514552 [Abstract] [Full Text] [Related]
14. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease. Gearry RB, Barclay ML. J Gastroenterol Hepatol; 2005 Aug; 20(8):1149-57. PubMed ID: 16048561 [Abstract] [Full Text] [Related]
15. Thiopurine methyltransferase enzyme activity determination before treatment of inflammatory bowel disease with azathioprine: effect on cost and adverse events. Sayani FA, Prosser C, Bailey RJ, Jacobs P, Fedorak RN. Can J Gastroenterol; 2005 Mar; 19(3):147-51. PubMed ID: 15776134 [Abstract] [Full Text] [Related]
16. High prevalence of polymorphism and low activity of thiopurine methyltransferase in patients with inflammatory bowel disease. Larussa T, Suraci E, Lentini M, Nazionale I, Gallo L, Abenavoli L, Imeneo M, Costanzo FS, Cuda G, Luzza F. Eur J Intern Med; 2012 Apr; 23(3):273-7. PubMed ID: 22385887 [Abstract] [Full Text] [Related]
17. Choice of azathioprine or 6-mercaptopurine dose based on thiopurine methyltransferase (TPMT) activity to avoid myelosuppression. A prospective study. Gisbert JP, Luna M, Maté J, González-Guijarro L, Cara C, Pajares JM. Hepatogastroenterology; 2006 Apr; 53(69):399-404. PubMed ID: 16795981 [Abstract] [Full Text] [Related]
18. Clinical use and practical application of TPMT enzyme and 6-mercaptopurine metabolite monitoring in IBD. Seidman EG. Rev Gastroenterol Disord; 2003 Apr; 3 Suppl 1():S30-8. PubMed ID: 12684587 [Abstract] [Full Text] [Related]
19. Influences of thiopurine methyltransferase genotype and activity on thiopurine-induced leukopenia in Korean patients with inflammatory bowel disease: a retrospective cohort study. Kim JH, Cheon JH, Hong SS, Eun CS, Byeon JS, Hong SY, Kim BY, Kwon SH, Kim SW, Han DS, Yang SK, Kim WH. J Clin Gastroenterol; 2010 Apr; 44(10):e242-8. PubMed ID: 20308917 [Abstract] [Full Text] [Related]
20. The role of genetic variation in thiopurine methyltransferase activity and the efficacy and/or side effects of azathioprine therapy in dermatologic patients. Snow JL, Gibson LE. Arch Dermatol; 1995 Feb; 131(2):193-7. PubMed ID: 7857117 [Abstract] [Full Text] [Related] Page: [Next] [New Search]